Bharat Parenterals Ltd.

NSE: BPLPHARMA · Pharmaceuticals · sector

₹1,802.20NSE close 2026-10-26

Key numbers

Market cap₹647 cr

Price₹1,802.20

52w high / low₹2,278 / ₹1,126

P/E40.0xSector median 27.9x

P/B2.0xSector median 2.9x

Book value₹898.0

Dividend yield0.11%Sector median 0.48%

ROE-4.7%Sector median 11.7%

ROCE-3.0%Sector median 12.3%

OPM3.3%Sector median 14.0%

Debt / equity0.45xSector median 0.16x

EV/EBITDA73.4xSector median 18.6x

Interest cover-1.2x

Current ratio1.99x

Sales growth 3y+16.6%Sector median +9.6%

Profit growth 3y–Sector median +13.3%

PEG–

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹17 cr vs borrowings ₹146 cr (FY26): borrowings are higher by ₹129 cr.
Operating profit covered interest -1.2x in the last 12 months.
Net loss in 5 of the last 6 quarters.
No dividend in the last 5 financial years.
Price ₹1,802.20 on 2026-10-26: -20.9% from the 52-week high, +60.1% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹1,864.00 · low ₹840.55

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	104	116	65	65	100	94
EBITDA	2	14	1	2	-1	9
OPM %	2.1%	11.9%	1.3%	2.7%	-0.5%	9.1%
Other income	2	1	4	1	4	1
Net profit	-9	-1	-7	-4	-5	1
EPS (₹)	14.40	1.27	14.00	14.03	11.84	5.17
Revenue YoY					-4.2%	-19.2%
Profit YoY					–	–

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	212	218	254	340	345	323
EBITDA	28	21	28	3	16	11
Net profit	21	24	23	-44	-8	-15
EPS (₹)	37.11	42.40	38.81	66.64	39.62	45.04
Revenue growth		+2.8%	+16.6%	+33.9%	+1.5%	–
Profit growth		+14.3%	-7.2%	-293.4%	–	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+16.6%	–	–
Net profit	–	–	–
EPS	-2.2%	–	–
Share price	–	– (2y)	–

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	331	322
Borrowings	180	146
Cash & equivalents	63	17
Total assets	649	613
Fixed assets	199	202
Capital work in progress	30	34
Investments	0	1
Receivables	172	151
Inventory	72	85
Payables	74	64

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	-27	38
Cash from investing	-137	9
Cash from financing	156	-47
Capex	29	40
Free cash flow	-56	-2

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	-13.2%	-2.5%
ROCE %	-4.1%	-1.9%
Debtor days	184	159
Inventory days	142	162
Payable days	146	122
Cash conversion cycle (days)	180	199
Working capital days	147	164

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
BPLPHARMA	₹647 cr	40.0x	2.0x	-4.7%	-3.0%	3.3%	+16.6%	0.11%

All 185 companies in Pharmaceuticals →

Dividends & corporate actions

Ex-date	Action	Detail
2026-09-11	Dividend	Dividend - Re 1 Per Share

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	BPLPHARMA
BSE code	541096
ISIN	INE365Y01019
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = NSE close 2026-10-26.